Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Acerus Pharmaceuticals Corp ASPCQ

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in... see more

OTCPK:ASPCQ - Post Discussion

Acerus Pharmaceuticals Corp > 33% of our leadership team has flown the coop recently
View:
Post by PitchinPennies on Nov 21, 2022 12:19pm

33% of our leadership team has flown the coop recently

Follow along using this handy bingo card. 

Motz has plotzed, and Hickey just wasn't sticky.

Who will be next to make for the exit? I hope it's not the chief medical officer, because he'll be Sorli missed. (@Jojorabbit11, I'll need to explain to you that was a joke about the fellow's name.)

One leader who can be relied on to stick around for the long haul is S-l-o-w as S*** Eddie.

After all, where does he have to go?

User image
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities